Fresenius Medical Care AG & Co. KGaA (FMEA) — Capital Reinvestment Ratio
Fresenius Medical Care AG & Co. KGaA (FMEA) has a Capital Reinvestment Ratio of 0.84x as of March 2026, meaning it reinvests 1% of its operating cash flow (€226.89 Million) in capital expenditures (€190.07 Million). Check Fresenius Medical Care AG & Co. KGaA tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio (2016–2025)
This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Fresenius Medical Care AG & Co. KGaA (FMEA) cash conversion ratio.
Annual Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA (2016–2025)
Year-by-year Capital Reinvestment Ratio for Fresenius Medical Care AG & Co. KGaA from 2016 to 2025. See FMEA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €2.68 Billion | €915.37 Million | ▲ +16.5% |
| 2024 | 0.29x | €2.39 Billion | €699.36 Million | ▲ +12.5% |
| 2023 | 0.26x | €2.63 Billion | €684.60 Million | ▼ -22.0% |
| 2022 | 0.33x | €2.17 Billion | €723.99 Million | ▼ -2.7% |
| 2021 | 0.34x | €2.49 Billion | €854.36 Million | ▲ +38.1% |
| 2020 | 0.25x | €4.23 Billion | €1.05 Billion | ▼ -43.3% |
| 2019 | 0.44x | €2.57 Billion | €1.12 Billion | ▼ -14.5% |
| 2018 | 0.51x | €2.06 Billion | €1.06 Billion | ▲ +19.0% |
| 2017 | 0.43x | €2.19 Billion | €944.46 Million | ▼ -15.0% |
| 2016 | 0.51x | €1.93 Billion | €979.36 Million | — |